Early predictors of outcomes in pediatric lupus nephritis: Focus on proliferative lesions

被引:39
作者
Wu, Jhong-Yong [1 ]
Yeh, Kuo-Wei [1 ]
Huang, Jing-Long [1 ]
机构
[1] Chang Gung Univ, Chang Gung Mem Hosp Linkuo, Div Allergy Asthma & Rheumatol, Dept Pediat, Tao Yuan, Taiwan
关键词
Lupus nephritis; Children; Outcomes; Predictors; TERM-FOLLOW-UP; CHILDHOOD-ONSET; SINGLE-CENTER; PROGNOSTIC-SIGNIFICANCE; DISEASE-ACTIVITY; CONTROLLED-TRIAL; ERYTHEMATOSUS; CHILDREN; CLASSIFICATION; THERAPY;
D O I
10.1016/j.semarthrit.2013.07.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Studies regarding the clinical features and outcomes of pediatric lupus nephritis are limited, and risk factors of poor outcome in the more severe form of renal involvement, proliferative lupus nephritis (PLN), are poorly understood. This study analyzed the data from a large prospective cohort of childhood systemic lupus erythematosus to determine such risk factors. Methods: Subjects younger than 18 years at onset with biopsy-proven lupus nephritis were enrolled. Data on baseline presentations and laboratory values, response to treatment, and outcomes were collected. Primary outcome measures were death or end-stage renal disease (ESRD). Survival analysis was done and predictors were approached. Results: One hundred four patients with mean age of 12.4 +/- 2.5 years (range, 4.0-17.2 years) and the female-to-male ratio of 5.94:1 were included. Among them, 81 patients had PLN and 23 had non-proliferative lupus nephritis. Those with PLN had significantly lower GFR, more proteinuria, more urine sediment, more hypertension, and poor early response to treatment (within 6 months). There was no significant difference in extra-renal manifestations. All poor outcomes happened in the PLN group. The prognostic factors were high baseline SLEDAI-2k >20 (HR, 6.76; p = 0.002), baseline GFR <60 ml/min/m(2) (HR, 3.88; p = 0.022), and early responder (HR, 0.19; p = 0.013). Conclusions: Patients with pediatric lupus nephritis and high risk factor can be identified early by concomitantly considering their baseline features and early response, which provides a novel hint in decision for management decisions. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:513 / 520
页数:8
相关论文
共 55 条
[1]   Outcome of lupus nephritis in Iranian children: prognostic significance of certain features [J].
Ataei, Neamatollah ;
Haydarpour, Manijeh ;
Madani, Abbas ;
Esfahani, Seyed Taher ;
Hajizadeh, Niloufar ;
Moradinejad, Mohammad Hasan ;
Gholmohammadi, Taghi ;
Arbabi, Shahriar ;
Haddadi, Marzieh .
PEDIATRIC NEPHROLOGY, 2008, 23 (05) :749-755
[2]   THERAPY OF LUPUS NEPHRITIS - CONTROLLED TRIAL OF PREDNISONE AND CYTOTOXIC DRUGS [J].
AUSTIN, HA ;
KLIPPEL, JH ;
BALOW, JE ;
LERICHE, NGH ;
STEINBERG, AD ;
PLOTZ, PH ;
DECKER, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (10) :614-619
[3]  
Baqi N, 1996, J AM SOC NEPHROL, V7, P924
[4]   Mortality in systemic lupus erythematosus [J].
Bernatsky, S. ;
Boivin, J. -F. ;
Joseph, L. ;
Manzi, S. ;
Ginzler, E. ;
Gladman, D. D. ;
Urowitz, M. ;
Fortin, P. R. ;
Petri, M. ;
Barr, S. ;
Gordon, C. ;
Bae, S. -C. ;
Isenberg, D. ;
Zoma, A. ;
Aranow, C. ;
Dooley, M. -A. ;
Nived, O. ;
Sturfelt, G. ;
Steinsson, K. ;
Alarcon, G. ;
Senecal, J. -L. ;
Zummer, M. ;
Hanly, J. ;
Ensworth, S. ;
Pope, J. ;
Edworthy, S. ;
Rahman, A. ;
Sibley, J. ;
El-Gabalawy, H. ;
McCarthy, T. ;
Pierre, Y. St. ;
Clarke, A. ;
Ramsey-Goldman, R. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2550-2557
[5]   Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis [J].
Bertsias, George K. ;
Tektonidou, Maria ;
Amoura, Zahir ;
Aringer, Martin ;
Bajema, Ingeborg ;
Berden, Jo H. M. ;
Boletis, John ;
Cervera, Ricard ;
Doerner, Thomas ;
Doria, Andrea ;
Ferrario, Franco ;
Floege, Juergen ;
Houssiau, Frederic A. ;
Ioannidis, John P. A. ;
Isenberg, David A. ;
Kallenberg, Cees G. M. ;
Lightstone, Liz ;
Marks, Stephen D. ;
Martini, Alberto ;
Moroni, Gabriela ;
Neumann, Irmgard ;
Praga, Manuel ;
Schneider, Matthias ;
Starra, Argyre ;
Tesar, Vladimir ;
Vasconcelos, Carlos ;
van Vollenhoven, Ronald F. ;
Zakharova, Helena ;
Haubitz, Marion ;
Gordon, Caroline ;
Jayne, David ;
Boumpas, Dimitrios T. .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (11) :1771-1782
[6]   Lupus nephritis in childhood: a review of 53 patients followed at a single center [J].
Bogdanovic, R ;
Nikolic, V ;
Pasic, S ;
Dimitrijevic, J ;
Lipkovska-Markovic, J ;
Eric-Marinkovic, J ;
Ognjanovic, M ;
Minic, A ;
Stajic, N .
PEDIATRIC NEPHROLOGY, 2004, 19 (01) :36-44
[7]   Lupus nephritis: A critical review [J].
Borchers, Andrea T. ;
Leibushor, Naama ;
Naguwa, Stanley M. ;
Cheema, Gurtej S. ;
Shoenfeld, Yehuda ;
Gershwin, M. Eric .
AUTOIMMUNITY REVIEWS, 2012, 12 (02) :174-194
[8]   CONTROLLED TRIAL OF PULSE METHYLPREDNISOLONE VERSUS 2 REGIMENS OF PULSE CYCLOPHOSPHAMIDE IN SEVERE LUPUS NEPHRITIS [J].
BOUMPAS, DT ;
AUSTIN, HA ;
VAUGHN, EM ;
KLIPPEL, JH ;
STEINBERG, AD ;
YARBORO, CH ;
BALOW, JE .
LANCET, 1992, 340 (8822) :741-745
[9]   Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus [J].
Brunner, Hermine I. ;
Gladman, Dafna D. ;
Ibanez, Dominique ;
Urowitz, Murray D. ;
Silverman, Earl D. .
ARTHRITIS AND RHEUMATISM, 2008, 58 (02) :556-562
[10]   Risk factors for damage in childhood-onset systemic lupus erythematosus - Cumulative disease activity and medication use predict disease damage [J].
Brunner, HI ;
Silverman, ED ;
To, T ;
Bombardier, C ;
Feldman, BM .
ARTHRITIS AND RHEUMATISM, 2002, 46 (02) :436-444